Molecular Docking and Clinical Study of Inhibition of Phytochemical Compounds of Nigella Sativa, Matricaria Chamomilla and Origanum Vulgare L on COVID_19 Mpro

01 December 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Due to the high rate of infection reported in the new Coronavirus, in recent months, a lot of research has been done on the introduction of antiviral drugs. Recent studies have shown that inhibiting viral protease enzymes are highly effective in controlling infection caused by any type of virus. The aim of this study was to investigate the bioinformatics of inhibition of the new coronavirus protease enzyme by compounds in the essential oils of three medicinal plants. This is a descriptive-analytical study. For this bioinformatics analysis, the structure of compounds from PubChem database and the structure of COVID_19 protease enzyme were obtained from PDB database. Molecular docking was then performed by MVD software. The results showed that the site of interaction of the compounds in the protected area is enzymatic flap. Also, 15 patients voluntarily received steam therapy with the essential oils of these plants and their symptoms of lung infection improved. Therefore, it can be concluded that the studied compounds with strong interaction due to their natural origin and the possibility of less side effects, as well as their direct entry into the respiratory tract, these compounds are suitable for drug treatment for coronavirus infection.

Keywords

COVID_19
Coronavirus
Bioinformatic
plant drug

Supplementary materials

Title
Description
Actions
Title
treat covid - Copy - Copy
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.